首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18292篇
  免费   1556篇
  国内免费   1476篇
耳鼻咽喉   209篇
儿科学   189篇
妇产科学   205篇
基础医学   2037篇
口腔科学   343篇
临床医学   2436篇
内科学   2770篇
皮肤病学   123篇
神经病学   958篇
特种医学   546篇
外国民族医学   16篇
外科学   1926篇
综合类   3351篇
现状与发展   5篇
一般理论   5篇
预防医学   1196篇
眼科学   428篇
药学   1999篇
  4篇
中国医学   909篇
肿瘤学   1669篇
  2024年   44篇
  2023年   292篇
  2022年   717篇
  2021年   870篇
  2020年   696篇
  2019年   602篇
  2018年   649篇
  2017年   610篇
  2016年   579篇
  2015年   849篇
  2014年   1020篇
  2013年   842篇
  2012年   1275篇
  2011年   1539篇
  2010年   969篇
  2009年   723篇
  2008年   894篇
  2007年   1035篇
  2006年   953篇
  2005年   943篇
  2004年   664篇
  2003年   612篇
  2002年   550篇
  2001年   485篇
  2000年   432篇
  1999年   430篇
  1998年   302篇
  1997年   319篇
  1996年   227篇
  1995年   225篇
  1994年   169篇
  1993年   128篇
  1992年   132篇
  1991年   107篇
  1990年   87篇
  1989年   74篇
  1988年   91篇
  1987年   57篇
  1986年   46篇
  1985年   32篇
  1984年   18篇
  1983年   9篇
  1982年   7篇
  1981年   7篇
  1980年   6篇
  1979年   7篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.

Purpose

Every year, almost one million individuals are diagnosed with hepatocellular carcinoma (HCC) worldwide and more than 690,000 patients die of it. At present, most therapeutic anti-HCC agents are not effective, which is due to the appearance of chemo-resistance and/or toxic side effects. Therefore, it is imperative to find novel more effective anti-HCC agents. Here, we evaluated the effect of giganteaside D (GD), an oleanolic acid saponin from P. scabiosaefolia, on the growth and apoptosis of HCC cells.

Methods and results

Using MTT and clonogenic assays, we found that GD exhibited a significant growth inhibitory effect on the HCC-derived cell lines HepG2 and Bel-7402. In addition, we found that GD induced mitochondria-mediated apoptosis in these HCC-derived cells, as indicated by a decreased mitochondrial potential, activation of Caspase-9 and Caspase-3, cleavage of PARP and release of Cytochrome C from the mitochondria. Besides, we found that GD stimulated the generation of reactive oxygen species (ROS) and that blockage of ROS attenuated the GD-induced mitochondria-mediated apoptosis. Additionally, we found that GD treatment led to a decrease in phosphorylated Erk (p-Erk) and triggered the generation of p-JNK, both components of the mitogen-activated protein kinase (MAPK) signaling pathway. Inhibition of Erk or JNK by specific inhibitors or siRNAs augmented or attenuated the cytotoxic and apoptotic effects of GD.

Conclusions

From our results we conclude that GD can induce ROS-mediated apoptosis in HCC-derived cells through the MAPK pathway. This observation may open up avenues to explore the future use of GD as a HCC chemotherapeutic agent.
  相似文献   
83.
OBJECTIVE: Discrepancies may exist between an original pathology report and formal pathology review, with subsequent implications for treatment. We conducted a study of pathology review in endometrial cancer from a population-based study to identify areas of discrepancy and effect on treatment. METHODS: This was a retrospective cohort study in Ontario, Canada from 1996 to 2000. We identified hysterectomy cases from patients with endometrial cancer that were subject to formal pathology review by a gynecologic pathologist at one of six tertiary care centers. Sarcomas and other rare histologic subtypes with fewer than five cases were excluded. We evaluated discrepancy between original pathology and review by demographics, stage, grade, and risk group. Four risk groups were defined: 1) low (stage I), 2) intermediate (stage I and II), 3) high-risk (stage I and II), and 4) advanced stage (all stage III and IV). Reclassification from one risk group to another upon pathology review represented a potential change in treatment. Factors associated with significant discrepancy were identified by a multivariable logistic regression model. RESULTS: Formal pathology review was available on 450 cases. There were no differences by age, year, or hospital type. The overall discrepancy rate was 42.7% (95% confidence interval 38.2-47.3%). The intermediate-risk group had the highest rate of reclassification into another group (33.1%). The most significant rates of discrepancy were associated with endometrioid grades 2 and 3 tumors and stage IIA disease (39.8%, 50.9%, and 79.6%, respectively). CONCLUSION: There was significant discrepancy between original pathology and formal review in endometrial cancer, with implications for guidelines on pathology review at a population level. LEVEL OF EVIDENCE: III  相似文献   
84.
NMDA受体属于谷氨酸受体,它在突触传递和突触可塑性中都发挥着非常重要的作用,其介导的兴奋性毒性是脑缺血、缺氧和脑外伤等导致脑损伤的重要分子机制.但是,近年来的研究发现,在生理和某些病理情况下,NMDA受体的激活具有促进神经元存活及保护神经元免受损伤的作用.  相似文献   
85.
慢性乙型肝炎患者的HDV感染   总被引:1,自引:0,他引:1  
作者对69例经病理确诊为慢性乙型肝炎患者,检测了肝内δ抗原(ABC免疫组化法)和血清δ抗体(ELISA法),结果57例肝组织有 7例检出δ抗原,39例血清中 7例检出δ抗体,无 1例 δ抗原和抗体同时阳性。HDV 标志的总检出率为20.3%(14/69)。CPH和CAH之间的HDVM检出率无显著性差异。HDV感染与无HDV感染者之间,HBV复制标志无差异。HDV 感染者蛋白质代谢紊乱程度较重。发现3例肝内δ抗原和血清HB-DNA均为阳性,显示重叠HDV感染,对HBV复制未见明显抑制。  相似文献   
86.
Improvementofheat-tolerancebytrainingI.Evaluationofeffectsoflong-distancerunningandmarchtrainingonheat-toleranceQiuRenzhi(邱仞之...  相似文献   
87.
本文报道9例在CT 和X 线平片上都有同一类型病理变化、发病机理和临床过程的胸腰椎压缩劈裂骨折.CT 上的共同病理变化为:(1)骨折椎的上椎间盘损伤;(2)椎体上1/2的压缩骨折:(3)椎体下1/2的矢状劈裂骨折:(4)椎管前部出现椎体中柱骨折块:(5)椎板骨折.通过对本类骨折的力学分析,作者认为这是—种独立的不稳定性爆裂骨折,且有神经性不稳定的特征.临床治疗应切开复位,并使用有撑开效应的固定器.  相似文献   
88.
非胰岛细胞瘤性低血糖的研究进展   总被引:1,自引:0,他引:1  
陈逸青  章秋 《医学综述》2013,(2):236-239
非胰岛细胞瘤性低血糖(NICTH)是一种胰岛细胞瘤以外的其他肿瘤导致的低血糖症。肿瘤组织分泌过多的胰岛素样生长因子Ⅱ(IGF-Ⅱ)的一种前体形式物质,因其相对分子质量较大,大多数文献称之为big-IGF-Ⅱ,它能产生类胰岛素样活性,故目前认为是导致患者反复出现低血糖的病因。诊断上主要依靠高水平的big-IGF-Ⅱ测定。NICTH的治疗方式较多,但治愈手段主要为手术切除肿瘤组织。现就NICTH的发病机制、临床表现、诊断及治疗等方面的研究进展予以综述。  相似文献   
89.
A new amdoparvovirus, named raccoon dog and fox amdoparvovirus (RFAV), was identified in farmed sick raccoon dogs and arctic foxes. Phylogenetic analyses showed that RFAV belongs to a new species within the genus Amdoparvovirus of the family Parvoviridae. An RFAV strain was isolated in Crandell feline kidney cell culture.  相似文献   
90.
医用电子仪器专业是一门新兴的交叉边沿性学科,分析近年来医电专业开设过程中所存在的问题.并对解决方案进行了探讨。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号